We're debuting a new look. See the updated format below. You'll now receive two short newsletters each month on the latest in the field of focused ultrasound.
The University of Queensland in Brisbane, Australia, recently announced that it received $10 million from the Federal Minister for Health to launch a clinical trial to treat 10 patients with Alzheimer’s disease by opening the blood-brain barrier with focused ultrasound and microbubbles.
When Ron learned he had Parkinson’s disease, he decided to forego invasive treatments and wait until he could participate in a focused ultrasound clinical trial.
With plans to initiate a new Alzheimer’s disease clinical trial, Dr. Jürgen Götz shared the progress that he and his team have made over the past few years.
A team at the Hospital for Sick Children (SickKids) is organizing a one-day event this spring for researchers, physicists, and clinicians with an interest in pediatric applications of focused ultrasound.
The Massive Open Online Course (MOOC) on Therapeutic Ultrasound has released a new course by Alexandre Carpentier, MD, PhD, on “Opening the Blood-Brain Barrier.”
Vesselon was founded to take microbubble technology from a diagnostic tool to a therapeutic agent. The company’s CEO Clay Larsen shares their progress and future goals.
